Catalog name Description price
R-M1-8465 mPEG2000-CPP10 CPP10 (Cell Penetrating Peptide 10) is a specific peptide sequence that is used as a cell-penetrating peptide in various biomedical and biotechnological applications. The CPP10 peptide is derived from the transactivator of transcription (Tat) protein of the human immunodeficiency virus (HIV), and consists of a sequence of 11 amino acids (YGRKKRRQRRR). The CPP10 peptide has a unique structure that enables it to efficiently cross the plasma membrane of cells, allowing it to deliver cargo molecules such as drugs, nucleic acids, or proteins to the intracellular environment. price>
R-M1-8478 YIGSR-PEG-N3  The laminin-derived peptide YIGSR (Tyr-Ile-Gly-Ser-Arg) inhibits human pre-B leukaemic cell growth and dissemination to organs in SCID mice. price>
R-M1-8489 DMG-PEG-R8 DMG-PEG-R8,DMG-PEG-octaarginine for enhanced delivery of a bioactive molecule into cells. The PEG2K component may contribute to improved stability and solubility, while the R8 component may aid in cellular uptake. price>
R-M1-8491 CY5-PEG-iRGD CY5-PEG-iRGD is a compound designed for targeted delivery and imaging in cancer research. It consists of three components: CY5, a red fluorescent dye for visualization purposes; PEG, a biocompatible polymer that enhances stability and biocompatibility; and iRGD, a peptide sequence that specifically targets tumor cells. price>
R-M1-8496 mpeg2000-SFSHHTPILPLCK MPEG2000-SFSHHTPILPLCK is a peptide sequence composed of specific amino acids. price>
R-M1-8507 SH-PEG3.4k-Angiopep2(TFFYGGSRGKRNNFKTEEYC) SH-PEG3.4K-Angiopep2 is a linear heterobifunctional PEG reagent with thiol and Angiopep2 (TFFYGGSRGKRNNFKTEEYC). price>
R-M1-8508 SH-PEG2k-Angiopep2(TFFYGGSRGKRNNFKTEEY) SH-PEG2k-Angiopep2(TFFYGGSRGKRNNFKTEEY),SH-PEG2000-TFFYGGSRGKRNNFKTEEYC is a linear heterobifunctional PEG reagent with thiol and Angiopep2 (TFFYGGSRGKRNNFKTEEYC). price>
R-M1-8518 Chol-PEG-CGSPWVRC Cholesterol-PEG-CGSPWVRC is a complex compound that consists of multiple components linked together.The combination of cholesterol, PEG, and CGSPWVRC can be used to create drug delivery systems or nanocarriers. The cholesterol component allows for the incorporation of the compound within cell membranes, while the PEG component provides stability and prolonged circulation in the body. The CGSPWVRC peptide sequence may have specific binding or targeting properties, which can be utilized to deliver drugs or other therapeutic agents to specific tissues or cells. Overall, the complex compound has the potential to enhance drug delivery efficiency and improve therapeutic outcomes. price>
R-M1-8521 TCO-PEG4-Fmoc-Gly-Gly-Gly TCO-PEG4-Fmoc-Gly-Gly-Gly is a compound that includes a TCO reactive group, a PEG chain, a protecting group (Fmoc) on a glycine residue, and a glycine linker sequence. This compound can be used in bioconjugation or peptide synthesis applications, where the TCO group can react with tetrazine-containing molecules, the PEG chain can improve solubility and stability, and the glycine residues can provide flexibility and aid in linking other components in a larger structure or biomolecule. price>
R-M1-8525 GGG-PEG4-DBCO-6 GGG-PEG4-DBCO-6 is a compound that combines a peptide spacer, a longer PEG chain, and a strain-promoted click chemistry reactive group, making it suitable for bioconjugation applications that require the enhanced solubility and steric hindrance provided by a longer PEG chain. price>